ASTEX PHARMACEUTICALS, INC Depreciation
ASTEX PHARMACEUTICALS, INC reported Depreciation of $603.00 thousand for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC depreciation for the quarter ending 2013-06-30 was $308.00K, a 28.37% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC depreciation for the quarter ending 2013-03-31 was $295.00K, a 33.56% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC depreciation for the quarter ending 2012-12-31 was $314.00K, a 27.31% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC depreciation for the quarter ending 2012-09-30 was $338.00K, a 21.21% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC depreciation for fiscal 2012 was $1.53M, a 6.19% increase from fiscal 2011.
- ASTEX PHARMACEUTICALS, INC depreciation for fiscal 2011 was $1.44M, a 12.27% increase from fiscal 2010.
- ASTEX PHARMACEUTICALS, INC depreciation for fiscal 2010 was $1.28M, a 4.83% increase from fiscal 2009.
- ASTEX PHARMACEUTICALS, INC depreciation for fiscal 2009 was $1.22M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2013-06-30 | $308.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $603.00K 10-Q · filed 2013-08-09 | $917.00K derived: sum of 3 quarters · filed 2013-08-09 | $1.25M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $295.00K 10-Q · filed 2013-05-10 | $609.00K derived: sum of 2 quarters · filed 2013-05-10 | $947.00K derived: sum of 3 quarters · filed 2013-05-10 | $1.38M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $652.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.08M derived: sum of 3 quarters · filed 2013-08-09 | $1.53M 10-K · filed 2013-03-18 |
| 2012-09-30 | $338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $768.00K derived: sum of 2 quarters · filed 2013-08-09 | $1.21M 10-Q · filed 2012-11-09 | $1.64M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $430.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $874.00K 10-Q · filed 2013-08-09 | $1.31M derived: sum of 3 quarters · filed 2013-08-09 | $1.74M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $444.00K 10-Q · filed 2013-05-10 | $876.00K derived: sum of 2 quarters · filed 2013-05-10 | $1.30M derived: sum of 3 quarters · filed 2013-05-10 | $1.59M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $861.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.15M derived: sum of 3 quarters · filed 2013-03-18 | $1.44M 10-K · filed 2013-03-18 |
| 2011-09-30 | $429.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $719.00K derived: sum of 2 quarters · filed 2012-11-09 | $1.00M 10-Q · filed 2012-11-09 | $1.34M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $576.00K 10-Q · filed 2012-08-09 | $913.00K derived: sum of 3 quarters · filed 2013-03-18 | $1.24M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $286.00K 10-Q · filed 2012-05-10 | $623.00K derived: sum of 2 quarters · filed 2013-03-18 | $946.00K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $660.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.28M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $943.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $620.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $1.22M 10-K · filed 2012-03-15 |